4.8 Review

Depression

期刊

LANCET
卷 392, 期 10161, 页码 2299-2312

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(18)31948-2

关键词

-

资金

  1. Australian Rotary Health
  2. National Institute of Mental Health
  3. National Health and Medical Research Council
  4. New South Wales Ministry of Health
  5. Ramsay Health
  6. University of Sydney
  7. AstraZeneca
  8. Eli Lilly Co
  9. Organon
  10. Pfizer
  11. Servier
  12. Wyeth

向作者/读者索取更多资源

Major depression is a common illness that severely limits psychosocial functioning and diminishes quality of life. In 2008, WHO ranked major depression as the third cause of burden of disease worldwide and projected that the disease will rank first by 2030.1 In practice, its detection, diagnosis, and management often pose challenges for clinicians because of its various presentations, unpredictable course and prognosis, and variable response to treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据